Analysts Viewpoint
Analysts review Arcutis Biotherapeutics Inc’s rating
In a filing, Arcutis Biotherapeutics Inc revealed its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on
Menu
In a filing, Arcutis Biotherapeutics Inc revealed its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Arcutis Biotherapeutics Inc’s filing revealed that its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on Mar
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Arcutis Biotherapeutics Inc revealed its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcutis Biotherapeutics
Arcutis Biotherapeutics Inc’s recently made public that its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on